Alexander, L., Anderson, D., Baxter, L., Claydon, M., Rucker, J., & Robinson, E. S. J. (2026). Preclinical models for evaluating psychedelics in the treatment of major depressive disorder. British Journal of Pharmacology, 183(14), 3970. https://doi.org/10.1111/bph.17370
Chicago Style (17th ed.) CitationAlexander, Laith, Dasha Anderson, Luke Baxter, Matthew Claydon, James Rucker, and Emma S. J. Robinson. "Preclinical Models for Evaluating Psychedelics in the Treatment of Major Depressive Disorder." British Journal of Pharmacology 183, no. 14 (2026): 3970. https://doi.org/10.1111/bph.17370.
MLA (9th ed.) CitationAlexander, Laith, et al. "Preclinical Models for Evaluating Psychedelics in the Treatment of Major Depressive Disorder." British Journal of Pharmacology, vol. 183, no. 14, 2026, p. 3970, https://doi.org/10.1111/bph.17370.